Cargando…
Lymph Node Dissection for Differentiated Thyroid Cancer
Lymph node metastases in differentiated thyroid cancer (DTC) have a wide spectrum of clinical significance. Several variables are taken under consideration when trying to decide on the optimal management of patients with DTC. Routine prophylactic central and/or lateral lymph node dissection is not a...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283708/ https://www.ncbi.nlm.nih.gov/pubmed/28117285 http://dx.doi.org/10.4274/2017.26.suppl.02 |
_version_ | 1782503537325899776 |
---|---|
author | Mizrachi, Aviram Shaha, Ashok R. |
author_facet | Mizrachi, Aviram Shaha, Ashok R. |
author_sort | Mizrachi, Aviram |
collection | PubMed |
description | Lymph node metastases in differentiated thyroid cancer (DTC) have a wide spectrum of clinical significance. Several variables are taken under consideration when trying to decide on the optimal management of patients with DTC. Routine prophylactic central and/or lateral lymph node dissection is not advocated with exception of central neck dissection for locally advanced tumors. When regarding recurrent disease, foundations have been laid for clinicians to make accurate decisions as to when to perform surgery and when to continue maintaining the patient’s disease under observation. These complex decisions are determined based upon multiple factors, not only regarding the patient’s disease but also the patient’s comprehension of the procedure and apprehension levels. Nevertheless if the patient and/or clinician are emotionally keen to surgically remove the disease then the procedure should be considered. |
format | Online Article Text |
id | pubmed-5283708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-52837082017-03-27 Lymph Node Dissection for Differentiated Thyroid Cancer Mizrachi, Aviram Shaha, Ashok R. Mol Imaging Radionucl Ther Review Lymph node metastases in differentiated thyroid cancer (DTC) have a wide spectrum of clinical significance. Several variables are taken under consideration when trying to decide on the optimal management of patients with DTC. Routine prophylactic central and/or lateral lymph node dissection is not advocated with exception of central neck dissection for locally advanced tumors. When regarding recurrent disease, foundations have been laid for clinicians to make accurate decisions as to when to perform surgery and when to continue maintaining the patient’s disease under observation. These complex decisions are determined based upon multiple factors, not only regarding the patient’s disease but also the patient’s comprehension of the procedure and apprehension levels. Nevertheless if the patient and/or clinician are emotionally keen to surgically remove the disease then the procedure should be considered. Galenos Publishing 2017-02 2017-01-09 /pmc/articles/PMC5283708/ /pubmed/28117285 http://dx.doi.org/10.4274/2017.26.suppl.02 Text en © Molecular Imaging and Radionuclide Therapy, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Mizrachi, Aviram Shaha, Ashok R. Lymph Node Dissection for Differentiated Thyroid Cancer |
title | Lymph Node Dissection for Differentiated Thyroid Cancer |
title_full | Lymph Node Dissection for Differentiated Thyroid Cancer |
title_fullStr | Lymph Node Dissection for Differentiated Thyroid Cancer |
title_full_unstemmed | Lymph Node Dissection for Differentiated Thyroid Cancer |
title_short | Lymph Node Dissection for Differentiated Thyroid Cancer |
title_sort | lymph node dissection for differentiated thyroid cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283708/ https://www.ncbi.nlm.nih.gov/pubmed/28117285 http://dx.doi.org/10.4274/2017.26.suppl.02 |
work_keys_str_mv | AT mizrachiaviram lymphnodedissectionfordifferentiatedthyroidcancer AT shahaashokr lymphnodedissectionfordifferentiatedthyroidcancer |